HEADER TRANSFERASE 10-DEC-22 8HOJ TITLE CRYSTAL STRUCTURE OF UGT71AP2 IN COMPLEX WITH UDP COMPND MOL_ID: 1; COMPND 2 MOLECULE: UGT71AP2; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCUTELLARIA BAICALENSIS; SOURCE 3 ORGANISM_TAXID: 65409; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GLYCOSYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.L.WANG,C.HE,F.LI,X.QIAO,M.YE REVDAT 2 26-JUN-24 8HOJ 1 JRNL REVDAT 1 13-DEC-23 8HOJ 0 JRNL AUTH Z.L.WANG,X.Q.DU,G.YE,H.T.WANG,Y.Z.LIU,C.R.LIU,F.D.LI, JRNL AUTH 2 H.AGREN,Y.ZHOU,J.H.LI,C.HE,D.A.GUO,M.YE JRNL TITL FUNCTIONAL CHARACTERIZATION, STRUCTURAL BASIS, AND PROTEIN JRNL TITL 2 ENGINEERING OF A RARE FLAVONOID 2'-O-GLYCOSYLTRANSFERASE JRNL TITL 3 FROM SCUTELLARIA BAICALENSIS. JRNL REF ACTA PHARM SIN B 2024 JRNL REFN ESSN 2211-3843 JRNL DOI 10.1016/J.APSB.2024.04.001 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.46 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 3 NUMBER OF REFLECTIONS : 19471 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.4600 - 5.5300 0.99 3101 168 0.1944 0.2490 REMARK 3 2 5.5300 - 4.4000 0.99 3000 130 0.2061 0.2608 REMARK 3 3 4.4000 - 3.8400 1.00 2957 157 0.2176 0.2671 REMARK 3 4 3.8400 - 3.4900 0.99 2917 165 0.2447 0.3334 REMARK 3 5 3.4900 - 3.2400 0.93 2730 162 0.2741 0.3243 REMARK 3 6 3.2400 - 3.0500 0.75 2191 107 0.2787 0.3173 REMARK 3 7 3.0500 - 2.9000 0.55 1606 80 0.2636 0.3297 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1300034035. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21963 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.12100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.79100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: 2ACW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM TARTRATE DIBASIC, 20% REMARK 280 W/V POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.36400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.27200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.36400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.27200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 LYS A 297 REMARK 465 PRO A 298 REMARK 465 GLU A 299 REMARK 465 LYS A 300 REMARK 465 GLY A 301 REMARK 465 ARG A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 GLU A 305 REMARK 465 TYR A 306 REMARK 465 GLU A 307 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 GLN B 74 REMARK 465 GLU B 75 REMARK 465 GLU B 76 REMARK 465 ASP B 77 REMARK 465 ASP B 238 REMARK 465 GLN B 239 REMARK 465 THR B 240 REMARK 465 GLN B 241 REMARK 465 GLY B 242 REMARK 465 PRO B 243 REMARK 465 VAL B 244 REMARK 465 GLY B 245 REMARK 465 ASP B 246 REMARK 465 LYS B 297 REMARK 465 PRO B 298 REMARK 465 GLU B 299 REMARK 465 LYS B 300 REMARK 465 GLY B 301 REMARK 465 ARG B 302 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 GLU B 305 REMARK 465 TYR B 306 REMARK 465 GLU B 307 REMARK 465 PHE B 398 REMARK 465 LYS B 399 REMARK 465 GLY B 400 REMARK 465 GLU B 401 REMARK 465 LYS B 402 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 48 CG CD CE NZ REMARK 470 LYS A 55 CG CD CE NZ REMARK 470 LYS A 174 CG CD CE NZ REMARK 470 ASP A 238 CG OD1 OD2 REMARK 470 LYS A 251 CG CD CE NZ REMARK 470 PHE A 398 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 399 CG CD CE NZ REMARK 470 GLU A 401 CG CD OE1 OE2 REMARK 470 LYS A 402 CG CD CE NZ REMARK 470 SER B 91 OG REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 LYS B 224 CG CD CE NZ REMARK 470 MET B 269 CG SD CE REMARK 470 ARG B 296 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 74 -157.55 -83.23 REMARK 500 SER A 78 -153.20 -85.10 REMARK 500 SER A 130 -164.39 -106.90 REMARK 500 LEU A 211 -73.64 -79.81 REMARK 500 GLU A 212 69.26 -101.50 REMARK 500 LYS A 224 47.69 -87.63 REMARK 500 GLN A 239 -1.42 61.40 REMARK 500 GLN A 241 -69.67 -97.47 REMARK 500 THR A 321 75.57 -110.34 REMARK 500 PRO A 332 96.41 -69.29 REMARK 500 LEU A 369 -70.94 -124.91 REMARK 500 ALA A 371 -147.63 56.93 REMARK 500 GLU A 401 33.99 -97.08 REMARK 500 LYS B 95 10.62 -68.05 REMARK 500 GLU B 147 -65.71 -123.14 REMARK 500 ASN B 149 76.51 54.04 REMARK 500 PRO B 198 9.98 -69.57 REMARK 500 PRO B 230 98.06 -68.13 REMARK 500 MET B 269 42.52 -144.04 REMARK 500 PRO B 332 95.23 -62.91 REMARK 500 LEU B 369 -65.25 -130.53 REMARK 500 ALA B 371 -142.59 58.75 REMARK 500 GLU B 384 -47.75 -134.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue UDP A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue UDP B 501 DBREF 8HOJ A 0 463 PDB 8HOJ 8HOJ 0 463 DBREF 8HOJ B 0 463 PDB 8HOJ 8HOJ 0 463 SEQRES 1 A 464 GLY MET THR ASN VAL GLU LEU VAL PHE ILE PRO SER PRO SEQRES 2 A 464 GLY LEU SER HIS LEU VAL SER THR VAL GLU ALA ALA LYS SEQRES 3 A 464 LEU LEU LEU HIS ARG ASP HIS ARG LEU SER ILE THR VAL SEQRES 4 A 464 LEU ILE THR ASN LEU HIS LYS ASP THR LYS VAL GLU ASN SEQRES 5 A 464 TYR THR LEU LYS THR THR SER ASN PRO ASN THR SER PRO SEQRES 6 A 464 ARG LEU ARG PHE ILE ASN LEU PRO THR GLN GLU GLU ASP SEQRES 7 A 464 SER ILE ASP SER GLN ILE ARG GLN VAL ARG GLU ILE VAL SEQRES 8 A 464 SER VAL LEU ILE LYS ASN PRO ASP SER LYS LEU GLY GLY SEQRES 9 A 464 LEU VAL LEU ASP MET PHE CYS THR SER PHE ILE GLN VAL SEQRES 10 A 464 ALA GLU GLU PHE ALA ILE PRO SER TYR VAL PHE PHE THR SEQRES 11 A 464 SER GLY ALA SER ALA LEU GLY LEU LEU GLN HIS LEU VAL SEQRES 12 A 464 SER LEU LYS LEU GLU HIS ASN GLN ASP LEU THR GLN PHE SEQRES 13 A 464 LYS ASP SER ASP VAL GLU LEU SER VAL PRO CYS PHE SER SEQRES 14 A 464 VAL PRO VAL PRO ALA LYS VAL LEU PRO ALA VAL MET VAL SEQRES 15 A 464 GLU GLY GLY PRO ILE GLU ASP THR PHE MET ASN TYR PHE SEQRES 16 A 464 LYS ARG ILE PRO GLU THR ARG GLY ILE MET VAL ASN THR SEQRES 17 A 464 PHE TYR GLU LEU GLU SER PHE ALA ILE GLN SER LEU LEU SEQRES 18 A 464 SER ASP ALA LYS ALA PRO LYS VAL TYR PRO VAL GLY PRO SEQRES 19 A 464 ILE LEU GLY PHE ASP GLN THR GLN GLY PRO VAL GLY ASP SEQRES 20 A 464 ASP ALA ILE LYS LYS TRP LEU ASP ASP GLN PRO GLU ASN SEQRES 21 A 464 SER VAL VAL PHE LEU CYS PHE GLY THR MET GLY SER PHE SEQRES 22 A 464 CYS GLU GLY GLN VAL LYS GLU ILE ALA MET ALA LEU GLU SEQRES 23 A 464 LYS SER GLY ASN ARG PHE LEU TRP SER LEU ARG LYS PRO SEQRES 24 A 464 GLU LYS GLY ARG VAL THR GLU TYR GLU ASN TYR GLU GLU SEQRES 25 A 464 VAL LEU PRO GLN GLY PHE LEU GLU ARG THR LYS GLY VAL SEQRES 26 A 464 GLY LYS VAL MET GLY TRP ALA PRO GLN ALA ALA VAL LEU SEQRES 27 A 464 SER HIS PRO ALA VAL GLY GLY PHE VAL SER HIS CYS GLY SEQRES 28 A 464 TRP ASN SER THR LEU GLU SER LEU TRP PHE GLY VAL PRO SEQRES 29 A 464 MET ALA THR PHE PRO LEU TYR ALA GLU GLN GLN MET ASN SEQRES 30 A 464 ALA PHE LEU LEU VAL LYS GLU GLU GLY MET ALA GLU MET SEQRES 31 A 464 ILE THR LEU ASP TYR LYS ILE ASP PHE LYS GLY GLU LYS SEQRES 32 A 464 GLN PRO GLU ILE VAL GLY SER ASP GLU ILE GLU ALA ALA SEQRES 33 A 464 ILE ARG ARG LEU MET ALA GLU GLU SER GLY VAL ARG ARG SEQRES 34 A 464 LYS VAL LYS GLU MET GLN ASN LYS ALA ARG SER ALA LEU SEQRES 35 A 464 LEU GLU GLY GLY SER SER TYR ASP ALA GLN CYS LEU PHE SEQRES 36 A 464 VAL HIS ASP VAL ILE ASN ASN ILE GLY SEQRES 1 B 464 GLY MET THR ASN VAL GLU LEU VAL PHE ILE PRO SER PRO SEQRES 2 B 464 GLY LEU SER HIS LEU VAL SER THR VAL GLU ALA ALA LYS SEQRES 3 B 464 LEU LEU LEU HIS ARG ASP HIS ARG LEU SER ILE THR VAL SEQRES 4 B 464 LEU ILE THR ASN LEU HIS LYS ASP THR LYS VAL GLU ASN SEQRES 5 B 464 TYR THR LEU LYS THR THR SER ASN PRO ASN THR SER PRO SEQRES 6 B 464 ARG LEU ARG PHE ILE ASN LEU PRO THR GLN GLU GLU ASP SEQRES 7 B 464 SER ILE ASP SER GLN ILE ARG GLN VAL ARG GLU ILE VAL SEQRES 8 B 464 SER VAL LEU ILE LYS ASN PRO ASP SER LYS LEU GLY GLY SEQRES 9 B 464 LEU VAL LEU ASP MET PHE CYS THR SER PHE ILE GLN VAL SEQRES 10 B 464 ALA GLU GLU PHE ALA ILE PRO SER TYR VAL PHE PHE THR SEQRES 11 B 464 SER GLY ALA SER ALA LEU GLY LEU LEU GLN HIS LEU VAL SEQRES 12 B 464 SER LEU LYS LEU GLU HIS ASN GLN ASP LEU THR GLN PHE SEQRES 13 B 464 LYS ASP SER ASP VAL GLU LEU SER VAL PRO CYS PHE SER SEQRES 14 B 464 VAL PRO VAL PRO ALA LYS VAL LEU PRO ALA VAL MET VAL SEQRES 15 B 464 GLU GLY GLY PRO ILE GLU ASP THR PHE MET ASN TYR PHE SEQRES 16 B 464 LYS ARG ILE PRO GLU THR ARG GLY ILE MET VAL ASN THR SEQRES 17 B 464 PHE TYR GLU LEU GLU SER PHE ALA ILE GLN SER LEU LEU SEQRES 18 B 464 SER ASP ALA LYS ALA PRO LYS VAL TYR PRO VAL GLY PRO SEQRES 19 B 464 ILE LEU GLY PHE ASP GLN THR GLN GLY PRO VAL GLY ASP SEQRES 20 B 464 ASP ALA ILE LYS LYS TRP LEU ASP ASP GLN PRO GLU ASN SEQRES 21 B 464 SER VAL VAL PHE LEU CYS PHE GLY THR MET GLY SER PHE SEQRES 22 B 464 CYS GLU GLY GLN VAL LYS GLU ILE ALA MET ALA LEU GLU SEQRES 23 B 464 LYS SER GLY ASN ARG PHE LEU TRP SER LEU ARG LYS PRO SEQRES 24 B 464 GLU LYS GLY ARG VAL THR GLU TYR GLU ASN TYR GLU GLU SEQRES 25 B 464 VAL LEU PRO GLN GLY PHE LEU GLU ARG THR LYS GLY VAL SEQRES 26 B 464 GLY LYS VAL MET GLY TRP ALA PRO GLN ALA ALA VAL LEU SEQRES 27 B 464 SER HIS PRO ALA VAL GLY GLY PHE VAL SER HIS CYS GLY SEQRES 28 B 464 TRP ASN SER THR LEU GLU SER LEU TRP PHE GLY VAL PRO SEQRES 29 B 464 MET ALA THR PHE PRO LEU TYR ALA GLU GLN GLN MET ASN SEQRES 30 B 464 ALA PHE LEU LEU VAL LYS GLU GLU GLY MET ALA GLU MET SEQRES 31 B 464 ILE THR LEU ASP TYR LYS ILE ASP PHE LYS GLY GLU LYS SEQRES 32 B 464 GLN PRO GLU ILE VAL GLY SER ASP GLU ILE GLU ALA ALA SEQRES 33 B 464 ILE ARG ARG LEU MET ALA GLU GLU SER GLY VAL ARG ARG SEQRES 34 B 464 LYS VAL LYS GLU MET GLN ASN LYS ALA ARG SER ALA LEU SEQRES 35 B 464 LEU GLU GLY GLY SER SER TYR ASP ALA GLN CYS LEU PHE SEQRES 36 B 464 VAL HIS ASP VAL ILE ASN ASN ILE GLY HET UDP A 501 25 HET UDP B 501 25 HETNAM UDP URIDINE-5'-DIPHOSPHATE FORMUL 3 UDP 2(C9 H14 N2 O12 P2) HELIX 1 AA1 GLY A 13 HIS A 29 1 17 HELIX 2 AA2 ASP A 46 SER A 58 1 13 HELIX 3 AA3 SER A 78 ILE A 94 1 17 HELIX 4 AA4 CYS A 110 SER A 112 5 3 HELIX 5 AA5 PHE A 113 PHE A 120 1 8 HELIX 6 AA6 GLY A 131 GLU A 147 1 17 HELIX 7 AA7 ASP A 151 LYS A 156 5 6 HELIX 8 AA8 LYS A 174 LEU A 176 5 3 HELIX 9 AA9 PRO A 177 VAL A 181 5 5 HELIX 10 AB1 GLY A 183 LYS A 195 1 13 HELIX 11 AB2 ARG A 196 THR A 200 5 5 HELIX 12 AB3 GLU A 212 ASP A 222 1 11 HELIX 13 AB4 ASP A 246 GLN A 256 1 11 HELIX 14 AB5 CYS A 273 GLY A 288 1 16 HELIX 15 AB6 GLY A 316 THR A 321 1 6 HELIX 16 AB7 PRO A 332 HIS A 339 1 8 HELIX 17 AB8 GLY A 350 PHE A 360 1 11 HELIX 18 AB9 GLU A 372 LYS A 382 1 11 HELIX 19 AC1 GLY A 408 MET A 420 1 13 HELIX 20 AC2 SER A 424 LEU A 442 1 19 HELIX 21 AC3 GLY A 445 ASN A 461 1 17 HELIX 22 AC4 LEU B 14 ASP B 31 1 18 HELIX 23 AC5 ASP B 46 ASN B 59 1 14 HELIX 24 AC6 ILE B 79 LYS B 95 1 17 HELIX 25 AC7 CYS B 110 SER B 112 5 3 HELIX 26 AC8 PHE B 113 PHE B 120 1 8 HELIX 27 AC9 GLY B 131 GLU B 147 1 17 HELIX 28 AD1 ASP B 151 LYS B 156 5 6 HELIX 29 AD2 GLY B 183 LYS B 195 1 13 HELIX 30 AD3 ARG B 196 THR B 200 5 5 HELIX 31 AD4 GLU B 212 ASP B 222 1 11 HELIX 32 AD5 ALA B 248 ASP B 254 1 7 HELIX 33 AD6 CYS B 273 GLY B 288 1 16 HELIX 34 AD7 ASN B 308 VAL B 312 5 5 HELIX 35 AD8 GLY B 316 THR B 321 1 6 HELIX 36 AD9 PRO B 332 HIS B 339 1 8 HELIX 37 AE1 GLY B 350 PHE B 360 1 11 HELIX 38 AE2 GLU B 372 LYS B 382 1 11 HELIX 39 AE3 GLY B 408 ALA B 421 1 14 HELIX 40 AE4 SER B 424 LEU B 442 1 19 HELIX 41 AE5 GLY B 445 ASN B 461 1 17 SHEET 1 AA1 7 LEU A 66 ASN A 70 0 SHEET 2 AA1 7 LEU A 34 ILE A 40 1 N VAL A 38 O ARG A 67 SHEET 3 AA1 7 VAL A 4 ILE A 9 1 N LEU A 6 O THR A 37 SHEET 4 AA1 7 LYS A 100 LEU A 106 1 O VAL A 105 N VAL A 7 SHEET 5 AA1 7 SER A 124 PHE A 128 1 O TYR A 125 N LEU A 104 SHEET 6 AA1 7 GLY A 202 VAL A 205 1 O MET A 204 N PHE A 128 SHEET 7 AA1 7 LYS A 227 PRO A 230 1 O TYR A 229 N ILE A 203 SHEET 1 AA2 2 GLU A 161 LEU A 162 0 SHEET 2 AA2 2 VAL A 171 PRO A 172 -1 O VAL A 171 N LEU A 162 SHEET 1 AA3 6 GLY A 325 MET A 328 0 SHEET 2 AA3 6 ARG A 290 SER A 294 1 N TRP A 293 O LYS A 326 SHEET 3 AA3 6 VAL A 261 CYS A 265 1 N LEU A 264 O SER A 294 SHEET 4 AA3 6 VAL A 342 SER A 347 1 O VAL A 346 N PHE A 263 SHEET 5 AA3 6 MET A 364 THR A 366 1 O ALA A 365 N PHE A 345 SHEET 6 AA3 6 ALA A 387 MET A 389 1 O GLU A 388 N THR A 366 SHEET 1 AA4 7 LEU B 66 ASN B 70 0 SHEET 2 AA4 7 LEU B 34 ILE B 40 1 N VAL B 38 O ARG B 67 SHEET 3 AA4 7 ASN B 3 ILE B 9 1 N LEU B 6 O THR B 37 SHEET 4 AA4 7 SER B 99 ASP B 107 1 O VAL B 105 N VAL B 7 SHEET 5 AA4 7 SER B 124 PHE B 128 1 O TYR B 125 N LEU B 106 SHEET 6 AA4 7 ILE B 203 VAL B 205 1 O MET B 204 N VAL B 126 SHEET 7 AA4 7 VAL B 228 PRO B 230 1 O TYR B 229 N ILE B 203 SHEET 1 AA5 2 GLU B 161 LEU B 162 0 SHEET 2 AA5 2 VAL B 171 PRO B 172 -1 O VAL B 171 N LEU B 162 SHEET 1 AA6 6 GLY B 325 MET B 328 0 SHEET 2 AA6 6 PHE B 291 SER B 294 1 N TRP B 293 O MET B 328 SHEET 3 AA6 6 VAL B 261 CYS B 265 1 N LEU B 264 O SER B 294 SHEET 4 AA6 6 VAL B 342 SER B 347 1 O VAL B 346 N PHE B 263 SHEET 5 AA6 6 MET B 364 THR B 366 1 O ALA B 365 N PHE B 345 SHEET 6 AA6 6 ALA B 387 MET B 389 1 O GLU B 388 N THR B 366 CISPEP 1 GLY A 232 PRO A 233 0 1.00 CISPEP 2 GLY B 232 PRO B 233 0 0.77 SITE 1 AC1 11 CYS A 265 TRP A 330 ALA A 331 GLN A 333 SITE 2 AC1 11 HIS A 348 GLY A 350 TRP A 351 ASN A 352 SITE 3 AC1 11 SER A 353 GLU A 356 TYR A 370 SITE 1 AC2 13 CYS B 265 GLY B 267 THR B 268 TRP B 330 SITE 2 AC2 13 ALA B 331 GLN B 333 HIS B 348 GLY B 350 SITE 3 AC2 13 TRP B 351 ASN B 352 SER B 353 GLU B 356 SITE 4 AC2 13 TYR B 370 CRYST1 104.728 108.544 84.350 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009549 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009213 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011855 0.00000